Fierce Biotech June 6, 2024
After taking 11 months to get to know Elsie Biotechnologies’ oligonucleotide platform, GSK is ready to tie the knot with a $50 million deal to acquire the West Coast biotech.
Elsie entered into a research collaboration with GSK in July 2023. The agreement positioned the companies to explore the potential of Elsie’s oligonucleotide discovery platform. Throughout the initial research term, GSK could option a non-exclusive license from Elsie for discovery and chemistry technologies to use in its own oligonucleotide drug discovery research. GSK took up the option in February.
Four months later, GSK is following in the footsteps of Victor “I liked it so much, I bought the company” Kiam. The drugmaker has paid up to $50 million to...
Today's Sponsors
Today's Sponsor